Literature DB >> 17079351

Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.

A B Soares1, L Ponchio, P B Juliano, V C de Araújo, A Altemani.   

Abstract

AIMS: To assess lymphatic vascular density (LVD) and lymph vessel endothelial proliferation in a series of carcinoma ex pleomorphic adenoma (CXPA) that represents the tumour in the different carcinogenesis phases and tumour progression.
METHODS: In 8 cases of early CXPA (intracapsular and minimally invasive tumours), 8 of advanced CXPA (widely invasive tumours) and 10 of pleomorphic adenoma (PA) without malignant transformation, lymphatic vessels and proliferating cells were detected using the antibodies D2-40 and Ki-67 respectively.
RESULTS: Comparing early tumours with advanced ones, LVD was not significantly different at the tumour margin. In contrast, regarding intratumoural lymphatics, PA without malignant transformation and early CXPA contained rare, if any, lymph vessels, whereas in widely invasive carcinomas they were more numerous. However, neither intratumoural nor peritumoural LVD were increased in comparison to adjacent normal salivary gland tissue. In no case did dual immunohistochemistry using D2-40 and the cell proliferation marker Ki-67 reveal the existence of proliferating lymphatics. Carcinomatous emboli were found in peritumoural as well as in intratumoural lymphatics only in advanced CXPA without myoepithelial differentiation.
CONCLUSION: In CXPA, the lymphatic network is mainly composed of pre-existing lymphatics which are rare in tumours that have not infiltrated outside the confines of the original PA. In the widely invasive CXPA, intratumoural as well as peritumoural lymphatics are a conduit for carcinoma cells, but in carcinomas with myoepithelial differentiation, the neoplastic cells seem to have a lower invasion capacity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079351      PMCID: PMC1972417          DOI: 10.1136/jcp.2006.042523

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  36 in total

1.  Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.

Authors:  T A Partanen; K Alitalo; M Miettinen
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

2.  Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.

Authors:  Zoltan Gombos; Xiaowei Xu; Christina S Chu; Paul J Zhang; Geza Acs
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

3.  Comparison of the diagnostic accuracy of lymphatic endothelium markers: Bayesian approach.

Authors:  Evangelos Evangelou; Panayiotis A Kyzas; Thomas A Trikalinos
Journal:  Mod Pathol       Date:  2005-11       Impact factor: 7.842

4.  Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung.

Authors:  Katharina Schmid; Peter Birner; Verena Gravenhorst; Adelheid End; Silvana Geleff
Journal:  Am J Surg Pathol       Date:  2005-03       Impact factor: 6.394

5.  Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Silvana Geleff; Anna Batistatou; Niki J Agnantis; Dimitrios Stefanou
Journal:  J Pathol       Date:  2005-06       Impact factor: 7.996

6.  LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer.

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; C Simopoulos; K C Gatter; A L Harris; D G Jackson
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

7.  Podoplanin: a novel diagnostic immunohistochemical marker.

Authors:  Nelson G Ordóñez
Journal:  Adv Anat Pathol       Date:  2006-03       Impact factor: 3.875

8.  Lymphangiogenesis does not occur in breast cancer.

Authors:  Beamon Agarwal; Romil Saxena; Akira Morimiya; Sanjana Mehrotra; Sunil Badve
Journal:  Am J Surg Pathol       Date:  2005-11       Impact factor: 6.394

9.  Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression.

Authors:  A Altemani; M T Martins; L Freitas; F Soares; N S Araújo; V C Araújo
Journal:  Histopathology       Date:  2005-06       Impact factor: 5.087

10.  Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.

Authors:  Vivien Schacht; Soheil S Dadras; Louise A Johnson; David G Jackson; Young-Kwon Hong; Michael Detmar
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

View more
  4 in total

1.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

2.  Differing Lymphatic Vessels Density in Salivary Adenoid Cystic Carcinoma and Pleomorphic Adenoma.

Authors:  Richard Salzman; I Stárek; L Kučerová; A Skálová
Journal:  Pathol Oncol Res       Date:  2016-11-11       Impact factor: 3.201

3.  Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma.

Authors:  R Salzman; I Stárek; L Kučerová; A Skálová; J Hoza
Journal:  Virchows Arch       Date:  2014-01       Impact factor: 4.064

4.  Primary intraosseous adenoid cystic carcinoma of the mandible: histopathological and immunohistochemical analysis.

Authors:  Román Carlos-Bregni; Elisa C Vidaurre; Ana Carolina Netto; Jorge E León; Oslei P Almeida
Journal:  Pathol Oncol Res       Date:  2009-04-21       Impact factor: 3.201

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.